Home News & Events Events Events Page tools Share Share Share on LinkedinShare on BlueskyShare on XShare on Facebook Print Search Email Accessibility Filter events Filter events by clicking within the ‘Category’ drop-down list. Category - Any - Industry Webinars Workshop Workshop NONMEM Introduction Workshop (China Region): Applications in PK/PD Modeling (Mandarin Language) Date 3 September 2026 Time 09:00 - 12:00 Location Online/Virtual Webex Timezone Asia/Shanghai Industry SCDM 2026 Annul Conference Date 14 September 2026 - 17 September 2026 Time 08:00 - 18:00 Location Raleigh, NC, USA Timezone EDT - America/New York ICON will exhibit | Booth #308 Industry OCT Southern California Date 15 September 2026 - 16 September 2026 Time 08:00 - 18:00 Location San Diego, CA, USA Timezone PDT - America/Los Angeles ICON will exhibit and speak | Booth#26 Workshop Beginners/Intermediate Online NONMEM/PDx-Pop Workshop Date 22 September 2026 - 23 September 2026 Time 09:00 - 17:00 Location Online/Virtual Webex Timezone America/New York Workshop Advanced Online NONMEM/PDx-Pop Workshop Date 24 September 2026 Time 09:00 - 17:00 Location Online/Virtual Webex Timezone America/New York Industry World Clinical Biomarkers & CDx Summit Date 5 October 2026 - 8 October 2026 Time 08:00 - 18:00 Location Boston, MA, USA Timezone EDT - America/New York ICON will exhibit and speak Industry CPHI Milan Date 6 October 2026 - 8 October 2026 Time 08:00 - 18:00 Location Milan, Italy Timezone Europe/Rome ICON will exhibit | Booth# 8F70 Workshop New and Advanced Features of NONMEM 7.6 at ACoP 2026 In Person Workshop Date 11 October 2026 Time 08:00 - 17:00 Location Gaylord National Resort & Convention Center, Oxon Hill, Maryland, USA. Timezone America/New York Industry Biomarkers and Precision Medicine Date 13 October 2026 - 14 October 2026 Time 08:00 - 18:00 Location Basel, Switzerland Timezone Europe/Zurich ICON will exhibit and speak | Booth #44 1 2 3 Next In this section In this section Press releases In the News Mediakit Facts and figures ICON spokespeople Awards Events Industry events ASCO 2026 ISPOR EU 2026 Webinars Workshops Webinars Social media hub Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Related information: Solutions Webinars Solutions Industry events Solutions Workshops What's happening in ICON ICON Plc Colleagues at our Mexico office put their gaming skills to the test earlier this month at the ICON4U Super Smash Bros. Ultimate Tournament. Organised by the ICON4U Engagement and Celebrations Chapter, the event welcomed... 13h View post ICON Plc ctDNA holds significant potential for accelerating cancer drug development, but acceptance as a primary surrogate endpoint remains a major regulatory challenge. ICON’s Bea Mann examines the scientific, regulatory and evi... 15h View post View webpage ICON Plc Latest issue now available. Join thousands of subscribers who have discovered the convenience of our free monthly publication, by signing up today. https://ow.ly/hTYQ50Zu7sT Compiled and collated by ICON’s Regulatory I... 30 Jul View post View webpage ICON Plc Accelerated approval is not a shortcut – it is a strategic decision that demands robust planning. In this latest Drug & Device World article, ICON’s Elizabeth Madichie and Jack Martin highlight why surrogate endpoints m... 30 Jul View post View webpage ICON Plc With more than 70 COPD therapies in development, differentiation has never been more important. As development programmes become increasingly targeted, sponsors must integrate biomarker-informed strategies, patient-focu... 29 Jul View post View webpage ICON Plc As more innovative therapies emerge from the APAC region, sponsors seeking global approval face increasingly complex regulatory decisions. Our latest article in PharmaTimes Magazine examines key considerations for navig... 29 Jul View post View webpage ICON Plc Heart failure affects millions of people worldwide and can significantly impact quality of life. Research into new treatment approaches remains critical to improving outcomes and expanding options for patients living wit... 28 Jul View post View webpage ICON Plc When Alyssa Gilliam joined ICON as a Clinical Trial Assistant in 1998, she expected it to be a temporary step. It became the start of a career shaped by new challenges, strong relationships and a willingness to keep lear... 28 Jul View post View webpage ICON Plc Global clinical development is entering a more connected, data-driven era. While the FDA is piloting real-time clinical trials, other regulatory bodies are advancing AI and digital strategies in different ways, creating... 27 Jul View post View webpage ICON Plc Italy's pharmaceutical traceability system is undergoing one of its most significant transformations in decades. New legislation will introduce a hybrid serialisation model that aligns Italy more closely with EU Falsifi... 24 Jul View post View webpage ICON Plc Earlier this month, colleagues from ICON Mexico came together for our fifth consecutive Blood Donation Campaign. Around 90 colleagues registered to take part, with 37 successfully donating blood following assessment by ... 21 Jul View post ICON Plc The EU’s PPWR is not a standalone regulatory change. It is a strategic transformation that touches the entire product lifecycle. In this article ICON’s Global Labelling & Ad Promotion team outlines practical recommendat... 21 Jul View post View webpage
